Asmar R, Hugues C, Pannier B, Daou J, Safar M E
Diagnosis Center, Broussais Hospital, Paris, France.
Eur Heart J. 1987 Dec;8 Suppl M:115-20. doi: 10.1093/eurheartj/8.suppl_m.115.
A pilot study was performed in hypertensive patients (a) to investigate the duration of blood pressure reduction produced by the new beta blocker bisoprolol (10 mg o.d.) after cessation of a 4 week treatment using non-invasive 24 hour ambulatory blood pressure measurements, (b) to study the effects of the drug on large arteries using non-invasive brachio-radial pulse wave velocity and aortic abdominal diameter measurements 3 hours after the last dose of a 4 week treatment. In comparison with the results obtained before treatment a significant reduction of blood pressure and heart rate was observed up to the 40th hour after treatment was terminated. The finding may be relevant for further evaluation of withdrawal phenomena produced by beta-blocking agents. The antihypertensive effect of bisoprolol was associated with significant decreases in brachio-radial pulse wave velocity (from 10.4 +/- 0.4 to 8.6 +/- 0.4 m s-1) and in aortic abdominal diameter (from 18.2 +/- 1.0 to 17.5 +/- 1.3 mm) indicating an increase in arterial distensibility. Further studies are needed to substantiate these observations and to reveal their mechanisms of action.
(a) 使用无创24小时动态血压测量法,调查新型β受体阻滞剂比索洛尔(每日10毫克)在4周治疗停止后血压降低的持续时间;(b) 在4周治疗的最后一剂药物服用3小时后,使用无创肱桡脉搏波速度和腹主动脉直径测量法研究该药物对大动脉的影响。与治疗前获得的结果相比,在治疗终止后的第40小时观察到血压和心率显著降低。这一发现可能与进一步评估β受体阻滞剂产生的撤药现象有关。比索洛尔的降压作用与肱桡脉搏波速度显著降低(从10.4±0.4降至8.6±0.4米/秒)和腹主动脉直径显著降低(从18.2±1.0降至17.5±1.3毫米)相关,表明动脉扩张性增加。需要进一步的研究来证实这些观察结果并揭示其作用机制。